SAN FRANCISCO, June 26, 2026 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced that, on June 19, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 20,500…
News provided by PR Newswire.
